These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8164768)

  • 1. [Current therapy of multiple sclerosis: mitoxantrone].
    Spuler S; Hohlfeld R
    Nervenarzt; 1994 Feb; 65(2):136-8. PubMed ID: 8164768
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunosuppressive therapy of multiple sclerosis with mitoxantrone].
    Mauch E; Kornhuber HH
    Fortschr Neurol Psychiatr; 1993 Dec; 61(12):410-7. PubMed ID: 8112704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic role of mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Pharmacol Ther; 2006 Jan; 109(1-2):198-209. PubMed ID: 16095713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mitoxanthrone in the therapy of multiple sclerosis].
    Kieseier BC; Gold R; Hartung HP
    Nervenarzt; 2003 Oct; 74(10):906-10. PubMed ID: 14551698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mitoxantrone].
    Pericot I; Montalban X
    Neurologia; 2003; 18(6):318-23. PubMed ID: 12838451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cladribine in chronic progressive multiple sclerosis].
    Weilbach FX; Hartung HP
    Nervenarzt; 1995 Apr; 66(4):299-303. PubMed ID: 7783818
    [No Abstract]   [Full Text] [Related]  

  • 7. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
    Neuhaus O; Kieseier BC; Hartung HP
    Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current therapy of multiple sclerosis--high-dose intravenous therapy with corticosteroids].
    Voltz R; Hohlfeld R
    Nervenarzt; 1992 Dec; 63(12):773-5. PubMed ID: 1494395
    [No Abstract]   [Full Text] [Related]  

  • 9. Mitoxantrone for worsening multiple sclerosis: tolerability, toxicity, adherence and efficacy in the clinical setting.
    Wundes A; Kraft GH; Bowen JD; Gooley TA; Nash RA
    Clin Neurol Neurosurg; 2010 Dec; 112(10):876-82. PubMed ID: 20727669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitoxantrone: multiple sclerosis: too many serious adverse effects.
    Prescrire Int; 2008 Feb; 17(93):17. PubMed ID: 18354876
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral, low-dosage methotrexate in chronic progressive multiple sclerosis. A preliminary critical analysis].
    Weilbach FX; Toyka KV; Hartung HP
    Nervenarzt; 1995 Aug; 66(8):643-7. PubMed ID: 7566279
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy-related acute nonlymphoblastic leukemia following mitoxantrone therapy in a patient with multiple sclerosis.
    Sumrall A; Dreiling B
    J Miss State Med Assoc; 2007 Jul; 48(7):206-7. PubMed ID: 17939254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the myocardial performance index for early detection of mitoxantrone-induced cardiotoxicity in patients with multiple sclerosis.
    Pattoneri P; Pelà G; Montanari E; Pesci I; Moruzzi P; Borghetti A
    Eur J Echocardiogr; 2007 Mar; 8(2):144-50. PubMed ID: 16603413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and multiple sclerosis: The devil is in the details.
    Bourdette D; Whitham R
    Neurology; 2010 May; 74(18):1410-1. PubMed ID: 20439842
    [No Abstract]   [Full Text] [Related]  

  • 15. Mitoxantrone in multiple sclerosis.
    Neuhaus O; Kieseier BC; Hartung HP
    Adv Neurol; 2006; 98():293-302. PubMed ID: 16400840
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute heart failure in a patient treated by mitoxantrone for multiple sclerosis].
    Feuillet L; Guedj E; Eusebio A; Malikova I; Pelletier J; Mundler O; Ali Chérif A;
    Rev Neurol (Paris); 2003 Dec; 159(12):1169-72. PubMed ID: 14978418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mitoxantrone, a new reality].
    Ruiz-Peña JL; Izquierdo G
    Rev Neurol; 2003 Apr 1-15; 36(7):698-9. PubMed ID: 12666055
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The first case of mitoxantrone exposure in early pregnancy.
    De Santis M; Straface G; Cavaliere AF; Rosati P; Batocchi AP; Caruso A
    Neurotoxicology; 2007 May; 28(3):696-7. PubMed ID: 17227680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rationale for the use of mitoxantrone in multiple sclerosis.
    Edan G; Morrissey S; Le Page E
    J Neurol Sci; 2004 Aug; 223(1):35-9. PubMed ID: 15261558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.